These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 4408033

  • 1. [Behavior of serum insulin under the influence of glisoxepide with and without butylbiguanide].
    Birk W, Petrides P.
    Arzneimittelforschung; 1974 Mar; 24(0):425-9. PubMed ID: 4408033
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Clinical experience with the blood sugar reducing sulfonamide derivative glisoxepide].
    Petzoldt R, Riedesel G, Ramrath M, Grabs V, Haupt E, Schwedes U, Ewald W, Beyer J, Schöffling K.
    Arzneimittelforschung; 1974 Mar; 24(0):429-32. PubMed ID: 4603399
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Pharmacologic study with glisoxepide and other blood sugar reducing sulfonamide derivatives in metabolically healthy subjects and diabetics].
    Haupt E, Beyer J, Schöffling K.
    Arzneimittelforschung; 1974 Mar; 24(0):418-25. PubMed ID: 4211557
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Multicentric clinical proof of a new oral antidiabetic glisoxepide (BS 4231). 3. Results of tolerance tests].
    Kiesselbach NH, Blumenbach L, Lehnert J.
    Arzneimittelforschung; 1974 Mar; 24(0):447-52. PubMed ID: 4603694
    [No Abstract] [Full Text] [Related]

  • 8. Biguanides. Mode of action and role in the up-to-date treatment of diabetes mellitus.
    Fövényi J.
    Ther Hung; 1971 Mar; 19(2):43-8. PubMed ID: 5172874
    [No Abstract] [Full Text] [Related]

  • 9. [Evaluation of a new sulfonylurea, glipizide, in the treatment of diabetes mellitus].
    Ninni M, Castelletta L.
    Minerva Med; 1973 Oct 10; 64(71):3725-31. PubMed ID: 4588364
    [No Abstract] [Full Text] [Related]

  • 10. [Treatment of diabetes mellitus with glibornurid].
    Vignati E, Liuzzi A, Chiodini PG.
    Minerva Med; 1973 Oct 24; 64(75):3900-6. PubMed ID: 4767761
    [No Abstract] [Full Text] [Related]

  • 11. [Progress in oral antidiabetic therapy].
    Rambert P.
    Therapeutique; 1973 Nov 24; 49(9):555-6. PubMed ID: 4600034
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Oral treatment of diabetes mellitus with the new sulfonylurea tolazamide].
    Vogel G, Krummel E.
    Arzneimittelforschung; 1969 Jul 24; 19(7):1128-30. PubMed ID: 5394514
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Modifications of glycemia and insulinemia in diabetics treated with glipizide (K 4024), a new sulfonylurea.
    Fedele D, Tiengo A, Riva F, Muggeo M, Emanueli A, Crepaldi G.
    Arzneimittelforschung; 1972 Nov 24; 22(11):1885-8. PubMed ID: 4679060
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [The pharmacological blockade of protein glycosylation in diabetes mellitus using sulfonylurea derivatives and biguanides].
    Lebedeva EA.
    Eksp Klin Farmakol; 1996 Nov 24; 59(5):40-2. PubMed ID: 9026209
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.